This page compiles legislation, rules, and policies regarding state
stem cell research programs. Much of this information is also contained in a
summary table of state policies compiled by
Susan Stayn of Stanford University.
For research funded by the California Institute for
Regenerative Medicine (CIRM):
California laws and guidelines for non-CIRM-funded research:
The National Center for Regenerative Medicine (NCRM) builds upon leading research and clinical programs at its founding institutions — Case Western Reserve University (CWRU), Cleveland Clinic (CC), and University Hospitals Case Medical Center (UHCMC) — in heart disease, cancer, genetic disorders, immunological, musculoskeletal, neurodegenerative diseases and wound healing, coupled with a 30-year history of research on adult and pluripotent stem cells at these institutions. This combination of outstanding clinical and research programs combined with tested and proven experience of using adult stem cell transplantation to treat patients makes this Center unique in the United States.
The NCRM is made up of two organizations, the Center for Stem Cell and Regenerative Medicine (CSCRM) and the Clinical Tissue Engineering Center (CTEC). Through investment by the State of Ohio's Third Frontier Commission, $44.5 million in funding has been received since 2003 to commercialize stem cell and tissue engineering therapies. $6.6 million in Federal appropriations has strengthened or created nearly 40 multi-institutional core facilities for Center members to access advanced regenerative medicine equipment and accelerate their research and clinical pursuits.
The broad-based excellence of its partner institutions provides the NCRM a comprehensive approach including basic and clinical research, biomedical and tissue engineering, and the development and administration of new therapies to patients with cancer and cardiovascular as well as blood, bone, immunological and nervous system diseases. The Center seeks to translate innovative laboratory research into the clinical and commercial arenas to replace and repair diseased tissues and organs. NCRM and its partner institutions and affiliated programs provide educational opportunities that enable nurses, graduate students, and technicians to gain the complex skills required to perform groundbreaking research and deliver optimal patient care in this new field. These efforts help create a well-trained workforce for the Center, for new businesses, and for other institutions.
Contacts for IASCR: Michael E. Gilkey, MBA, MS Acting Executive Director, National Center for Regenerative Medicine
